Changes in Synthetic Opioid Involvement in Drug Overdose Deaths in the United States, 2010-2016 - PubMed (original) (raw)

Changes in Synthetic Opioid Involvement in Drug Overdose Deaths in the United States, 2010-2016

Christopher M Jones et al. JAMA. 2018.

Abstract

This study uses National Vital Statistics System data to describe trends in synthetic opioid involvement in drug overdose deaths in the United States from 2010 to 2016.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Compton reported owning stock in General Electric, 3M, and Pfizer. No other disclosures were reported.

Figures

Figure.. Percentage of Synthetic Opioid-Related Overdose Deaths Involving Illicit or Psychotherapeutic Drugs or Alcohol in the United States, 2016

aDeaths are not mutually exclusive. Percentages sum to more than 100%.

Similar articles

• Trends in Deaths Involving Heroin and Synthetic Opioids Excluding Methadone, and Law Enforcement Drug Product Reports, by Census Region - United States, 2006-2015.
  O'Donnell JK, Gladden RM, Seth P. O'Donnell JK, et al. MMWR Morb Mortal Wkly Rep. 2017 Sep 1;66(34):897-903. doi: 10.15585/mmwr.mm6634a2. MMWR Morb Mortal Wkly Rep. 2017. PMID: 28859052 Free PMC article.
• Underlying Factors in Drug Overdose Deaths.
  Dowell D, Noonan RK, Houry D. Dowell D, et al. JAMA. 2017 Dec 19;318(23):2295-2296. doi: 10.1001/jama.2017.15971. JAMA. 2017. PMID: 29049472 Free PMC article. No abstract available.
• Fentanyl-laced street drugs "kill hundreds".
  Boddiger D. Boddiger D. Lancet. 2006 Aug 12;368(9535):569-70. doi: 10.1016/S0140-6736(06)69181-2. Lancet. 2006. PMID: 16909503 No abstract available.
• [Poisoning with amphetamines and designer drugs].
  Felgenhauer N, Zilker T. Felgenhauer N, et al. Internist (Berl). 1999 Jun;40(6):617-23. doi: 10.1007/s001080050379. Internist (Berl). 1999. PMID: 10420315 Review. German. No abstract available.
• [Death from fentanyl: Causative and preventive approaches in Bavaria].
  Erbas B, Arnold M. Erbas B, et al. MMW Fortschr Med. 2016 Feb 18;158(3):54-6. doi: 10.1007/s15006-016-7821-0. MMW Fortschr Med. 2016. PMID: 27119701 Review. German. No abstract available.

Cited by

• Buprenorphine, oxycodone, hydrocodone, and methadone mortality in the United States (2010‒2017).
  Rockhill KM, Bau GE, DeVeaugh-Geiss A, Chilcoat H, Dart R, Iwanicki J, Black JC. Rockhill KM, et al. J Am Coll Emerg Physicians Open. 2024 Oct 23;5(5):e13338. doi: 10.1002/emp2.13338. eCollection 2024 Oct. J Am Coll Emerg Physicians Open. 2024. PMID: 39449817 Free PMC article.
• Opioid-related mortality after occupational injury in Washington State: accounting for preinjury opioid use.
  Boden LI, Asfaw A, O'Leary PK, Tripodis Y, Busey A, Applebaum KM, Fox MP. Boden LI, et al. Occup Environ Med. 2024 Oct 23;81(10):515-521. doi: 10.1136/oemed-2024-109606. Occup Environ Med. 2024. PMID: 39327042
• Fentanyl-positive urine drug screens in the emergency department: Association with intentional opioid misuse and racial disparities.
  Shufflebarger EF, Reynolds LM, McNellage L, Booth JS, Brown J, Edwards AR, Li L, Robinett DA, Walter LA. Shufflebarger EF, et al. Drug Alcohol Depend Rep. 2024 Aug 3;12:100269. doi: 10.1016/j.dadr.2024.100269. eCollection 2024 Sep. Drug Alcohol Depend Rep. 2024. PMID: 39219738 Free PMC article.
• Misuse, Abuse and Medication Errors' Adverse Events Associated with Opioids-A Systematic Review.
  Gustafsson M, Silva V, Valeiro C, Joaquim J, van Hunsel F, Matos C. Gustafsson M, et al. Pharmaceuticals (Basel). 2024 Jul 31;17(8):1009. doi: 10.3390/ph17081009. Pharmaceuticals (Basel). 2024. PMID: 39204114 Free PMC article. Review.
• Strategies used to reduce harms associated with fentanyl exposure among rural people who use drugs: multi-site qualitative findings from the rural opioid initiative.
  Walters SM, Baker R, Frank D, Fadanelli M, Rudolph AE, Zule W, Fredericksen RJ, Bolinski R, Sibley AL, Go VF, Ouellet LJ, Pho MT, Seal DW, Feinberg J, Smith G, Young AM, Stopka TJ. Walters SM, et al. Harm Reduct J. 2024 Aug 24;21(1):154. doi: 10.1186/s12954-024-01062-2. Harm Reduct J. 2024. PMID: 39182116 Free PMC article.

References

1. 1. Centers for Disease Control and Prevention National Vital Statistics System 2016 Multiple Cause of Death File. Hyattsville, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2017.
2. 1. Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths—United States, 2010-2015. MMWR Morb Mortal Wkly Rep. 2016;65(5051):1445-1452. - PubMed
3. 1. Drug Enforcement Administration National drug threat assessment, 2017. https://www.dea.gov/docs/DIR-040-17_2017-NDTA.pdf. Accessed December 23, 2017.
4. 1. Tomassoni AJ, Hawk KF, Jubanyik K, et al. . Multiple fentanyl overdoses—New Haven, Connecticut, June 23, 2016. MMWR Morb Mortal Wkly Rep. 2017;66(4):107-111. - PMC - PubMed
5. 1. Carroll JJ, Marshall BDL, Rich JD, Green TC. Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: a mixed methods study. Int J Drug Policy. 2017;46:136-145. - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central
  • Silverchair Information Systems

• Other Literature Sources

  • scite Smart Citations